Terms ending in 2038
Every in-force patent on Ignyta, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,398,693 | Pharmaceutical Compositions and Dosage Forms In force · High confidence | Ignyta, Inc. | In force | High confidence | |
| US 11,253,515 | Pharmaceutical Compositions and Dosage Forms In force · High confidence | Ignyta, Inc. | In force | High confidence | |
| US 11,007,191 | Pharmaceutical Compositions and Dosage Forms In force · High confidence | Ignyta, Inc. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.